(redirected from AIDS dementia complex)
Also found in: Dictionary, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • all
  • adj
  • noun

Synonyms for complex

Synonyms for complex

consisting of two or more interconnected parts

a usually large entity composed of interconnected parts


a center of organization, supply, or activity

an exaggerated concern


Synonyms for complex

a conceptual whole made up of complicated and related parts


Related Words

a compound described in terms of the central atom to which other atoms are bound or coordinated

(psychoanalysis) a combination of emotions and impulses that have been rejected from awareness but still influence a person's behavior

a whole structure (as a building) made up of interconnected or related structures

complicated in structure


References in periodicals archive ?
Lipton, Director of the Laboratory of Cellular and Molecular Neuroscience at Children's Hospital, said, "Excessive activation of the glutamate type of NMDA receptors appears to play a role in neuronal injury and death in a variety of pathologic conditions including chronic neurodegenerative disorders such as AIDS dementia complex.
Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex.
HIV disease has long been associated with a range of neurological complications with sensory neuropathies and AIDS dementia complex being the most common.
National Institutes of Health grants to support research in AIDS dementia complex, inflammatory bowel disease, and myocardial infarction.
For 9 percent of the patients, AIDS dementia complex was the only serious clinical manifestation of HIV (AIDS) infection before death.
Interim results for the AIDS dementia complex (ADC) Phase IIa clinical study of Centaur's compound, called CPI-1189, indicate that CPI-1189 was well tolerated with more than 90% of CPI-1189 treated patients completing the initial 10 week dosing period, compared to 76% in the placebo group.
The Board is strengthened by Dick's significant financial and pharmaceutical business development expertise and we will oversee a company that is poised to lead its stroke, Parkinson's, and AIDS dementia complex compounds through pivotal clinical trials.
Full browser ?